Clarivate · 2 months ago
Business Development Manager (Life Sciences & Healthcare)
Clarivate is seeking a Business Development Manager to join their Life Science Team. The role involves generating new business from small to mid-tier Pharma & Biotech, CROs, and other key industry stakeholders while maintaining a robust sales pipeline and collaborating with commercial teams.
AnalyticsInformation ServicesInformation TechnologyInnovation Management
Responsibilities
Proactive new business generation with a focus on mid-tier pharmaceutical and biotech companies, as well as other key industry stakeholders, in North American pharma markets
Maintaining a robust pipeline for future sales by sourcing new prospects as well as qualifying inbound leads for conversion
Engaging and communicating effectively with senior (often C-level) decision makers both over the telephone and face to face
Accurately maintaining and developing prospect/client data via Salesforce.com
Collaborating with other commercial teams to maximize revenue opportunities from prospects and existing clients
Developing and maintaining a high level of product knowledge across a broad range of DRG’s products and services
Attending conferences and events with the aim of developing new business and supporting existing clients
Qualification
Required
Bachelor's Degree or equivalent experience
2 years of experience in a sales capacity
Fluency in written & oral English is a must
Preferred
Degree in Pharmaceutical / Biotechnology related sciences, Life or Medical Sciences
Knowledge of the Life Sciences space or experience in the U.S. pharmaceutical industry
Business Intelligence or SaaS sales experience into the pharmaceutical sector, which should include proactive telephone-based new business generation
Strong commercial acumen with experience of presenting to senior decision makers in the Pharma sector
A Hunter Mentality and exert an abundance of confidence
Experience of attending and exhibiting at industry events and conferences
Company
Clarivate
Clarivate is a leading global provider of transformative intelligence.
Funding
Current Stage
Public CompanyTotal Funding
$94MKey Investors
Elliott Management Corp.
2022-11-15Post Ipo Equity· $94M
2021-02-01IPO
2016-10-04Acquired
Leadership Team
Recent News
Canada NewsWire
2025-12-18
Company data provided by crunchbase